ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Axitinib Shows Activity Against Advanced Thyroid Cancer

July 27, 2007

In Brief: House Passes Bill Extending Saccharin Status To 1981; Execs No Enthusiastic Over New SES

August 3, 1979

James Shannon, 89, Led NIH In 1960’s Period of Growth

May 27, 1994

RFA On Promoters, Hormones, Other Cofactors Available

July 17, 1981

Sustained-Release Leuprolide Under Study In Phase III Trial.

June 30, 2000

Phase III Trial of Alimta, Avastin Combination Fails Endpoint to Improve Overall Survival

September 28, 2012